收稿日期: 2025-03-17
网络出版日期: 2025-06-19
基金资助
国家自然科学基金项目(81960439);广西壮族自治区卫健委自筹项目(Z-A20240981)
The impact of RAB2B on pancreatic cancer proliferation and metastasis via the NF⁃κB pathway
Received date: 2025-03-17
Online published: 2025-06-19
目的 研究RAB2B对胰腺癌细胞生物学行为的影响。 方法 在5株胰腺癌细胞中选出相对高表达RAB2B的PANC-1及相对低表达的BXPC-3细胞,利用细胞转染技术,将RAB2B-siRNA和pcDNA3.1-RAB2B质粒分别转染到PANC-1和BXPC-3细胞。CCK8实验用于检测干预RAB2B后胰腺癌细胞的增殖能力,细胞划痕实验和Transwell小室实验用于检测细胞的迁移和侵袭能力。使用qRT-PCR和蛋白印迹法(WB)分别检测RAB2B、NF-κB、FN1在mRNA及蛋白水平的表达情况。 结果 转染后的PANC-1细胞,其RAB2B的mRNA量及蛋白表达水平均显著下降(P < 0.05);CCK8结果显示敲低RAB2B后,PANC-1细胞的增殖能力显著降低(P < 0.05),划痕愈合能力明显下降(P < 0.01);Transwell结果显示细胞迁移数量明显减少(P < 0.01),WB显示磷酸化的p65和FN1的表达量明显下降(P < 0.01);而过表达RAB2B则逆转了上述改变。 结论 在PANC-1细胞中敲低RAB2B,可以抑制细胞的增殖和迁移能力,而在BXPC-3细胞中过表达RAB2B,可增强细胞的增殖和迁移能力,其机制可能与激活NF-κB通路进而调控FN1的表达有关。
李清 , 曾灵运 , 刘鑫 , 熊钰 , 宁静 , 覃山羽 , 陈秀秉 . RAB2B通过NF-κB通路对胰腺癌增殖和转移的影响[J]. 实用医学杂志, 2025 , 41(11) : 1637 -1644 . DOI: 10.3969/j.issn.1006-5725.2025.11.005
Objective To investigate the effects of Ras?related protein Rab?2B (RAB2B) on the biological behaviors of pancreatic cancer cells and elucidate its underlying mechanism. Methods PANC?1 cells, which exhibit relatively high RAB2B expression, and BXPC?3 cells, which display relatively low RAB2B expression, were selected from five pancreatic cancer cell lines. RAB2B?siRNA and pcDNA3.1?RAB2B plasmids were transfected into PANC?1 and BXPC?3 cells using a cell transfection technique. The CCK?8 assay was employed to evaluate the proliferative capacity of pancreatic cancer cells following RAB2B intervention. Wound healing and Transwell chamber assays were utilized to assess the migratory and invasive capabilities of pancreatic cancer cells. Additionally, the mRNA and protein expression levels of RAB2B, NF?κB, and Fibronectin 1 (FN1) were analyzed by qRT?PCR and Western blot (WB), respectively. Results RAB2B mRNA and protein expression levels were significantly downregulated in PANC?1 cells following transfection (P < 0.05). CCK?8 assay results demonstrated that the proliferative capacity of PANC?1 cells was markedly reduced (P < 0.05), and the wound?healing ability was substantially impaired (P < 0.01) upon RAB2B knockdown. Transwell assays revealed a significant decrease in cell migration (P < 0.01), while Western blot analysis indicated that the expression levels of phosphorylated p65 and FN1 were notably diminished (P < 0.01). Conversely, overexpression of RAB2B reversed these aforementioned alterations. Conclusions Knockdown of RAB2B in PANC?1 cells significantly suppresses cell proliferation and migration, whereas overexpression of RAB2B in BXPC?3 cells markedly promotes these processes. This effect is likely mediated through the activation of the NF?κB signaling pathway and the subsequent regulation of FN1 expression.
| 1 | SIEGEL R L, GIAQUINTO A N, JEMAL A. Cancer statistics, 2024[J]. CA Cancer J Clin, 2024, 74(1):12-49. doi:10.3322/caac.21820 |
| 2 | STOFFEL E M, BRAND R E, GOGGINS M. Pancreatic Cancer: Changing Epidemiology and New Approaches to Risk Assessment, Early Detection, and Prevention[J]. Gastroenterology, 2023, 164(5):752-765. doi:10.1053/j.gastro.2023.02.012 |
| 3 | GUADAGNO N A, PROGIDA C. Rab GTPases: Switching to Human Diseases[J]. Cells, 2019, 8(8):909. doi:10.3390/cells8080909 |
| 4 | PARK J I, SONG K H, KANG S M,et al. BHMPS Inhibits Breast Cancer Migration and Invasion by Disrupting Rab27a-Mediated EGFR and Fibronectin Secretion[J]. Cancers (Basel),2022, 14(2):373. doi:10.3390/cancers14020373 |
| 5 | CULINE S, HONORE N, CLOSSON V, et al. A small GTP-binding protein is frequently overexpressed in peripheral blood mononuclear cells from patients with solid tumours[J]. Eur J Cancer, 1994, 30(5): 670-674. doi:10.1016/0959-8049(94)90542-8 |
| 6 | ZHEN Y, STENMARK H. Cellular functions of Rab GTPases at a glance[J]. J Cell Sci, 2015, 128(17):3171-3176. |
| 7 | CHEN X, LIAO X, ZHENG B, et al. Differential Plasma Proteins Identified via iTRAQ‐Based Analysis Serve as Diagnostic Markers of Pancreatic Ductal Adenocarcinoma[J]. Dis Markers, 2023, 2023(1): 5145152. doi:10.1155/2023/5145152 |
| 8 | MALESCI A, TOMMASINI M A, BONATO C, et al. Determination of CA 19-9 antigen in serum and pancreatic juice for differential diagnosis of pancreatic adenocarcinoma from chronic pancreatitis[J]. Gastroenterology, 1987, 92(1):60-67. doi:10.1016/0016-5085(87)90840-7 |
| 9 | LUO G, JIN K, DENG S, et al. Roles of CA19-9 in pancreatic cancer: Biomarker, predictor and promoter[J]. Biochim Biophys Acta Rev Cancer, 2021, 1875(2):188409. doi:10.1016/j.bbcan.2020.188409 |
| 10 | BALLEHANINNA U K, CHAMBERLAIN R S. The clinical utility of serum CA 19-9 in the diagnosis, prognosis and management of pancreatic adenocarcinoma: An evidence based appraisal[J]. J Gastrointest Oncol, 2012, 3(2):105-119. doi:10.1007/s13193-011-0042-1 |
| 11 | HOMMA Y, HIRAGI S, FUKUDA M. Rab family of small GTPases: An updated view on their regulation and functions[J]. FEBS J, 2021, 288(1):36-55. doi:10.1111/febs.15453 |
| 12 | XU S, CAO B, XUAN G, et al. Function and regulation of Rab GTPases in cancers[J]. Cell Biol Toxicol, 2024, 40(1):28. doi:10.1007/s10565-024-09866-5 |
| 13 | TANG Q, LENTO A, SUZUKI K, et al. Rab11-FIP1 mediates epithelial-mesenchymal transition and invasion in esophageal cancer[J]. EMBO Rep, 2021, 22(2):e48351. doi:10.15252/embr.201948351 |
| 14 | KAJIHO H, KAJIHO Y, SCITA G. Harnessing membrane trafficking to promote cancer spreading and invasion: The case of RAB2A[J]. Small GTPases, 2018, 9(4):304-309. doi:10.1080/21541248.2016.1223990 |
| 15 | WANG J, LUO X, LU J, et al. Rab22a promotes the proliferation, migration, and invasion of lung adenocarcinoma via up-regulating PI3K/Akt/mTOR signaling pathway[J]. Exp Cell Res, 2022, 416(2):113179. doi:10.1016/j.yexcr.2022.113179 |
| 16 | JIANG C, LIU Z, YUAN J, et al. Construction of Two Independent RAB Family-Based Scoring Systems Based on Machine Learning Algorithms and Definition of RAB13 as a Novel Therapeutic Target for Hepatocellular Carcinoma[J]. Int J Mol Sci, 2023, 24(5):4335. doi:10.3390/ijms24054335 |
| 17 | JIN J, WU Y, ZHOU D, et al. miR-448 targets Rab2B and is pivotal in the suppression of pancreatic cancer[J]. Oncol Rep, 2018, 40(3):1379-1389. |
| 18 | HU Y, LI Y, HUANG Y, et al. METTL3 regulates the malignancy of cervical cancer via post-transcriptional regulation of RAB2B[J]. Eur J Pharmacol, 2020, 879:173134. doi:10.1016/j.ejphar.2020.173134 |
| 19 | TIAN Y, LUO Y, WANG J. MicroRNA-425 induces apoptosis and suppresses migration and invasion of human cervical cancer cells by targeting RAB2B[J]. Int J Immunopathol Pharmacol, 2021, 35:20587384211016131. doi:10.1177/20587384211016131 |
| 20 | PANKOV R, YAMADA K M. Fibronectin at a glance[J]. J Cell Sci, 2002, 115(20):3861-3863. doi:10.1242/jcs.00059 |
| 21 | ANSARI D, FRIESS H, BAUDEN M,et al.Pancreatic cancer: disease dynamics, tumor biology and the role of the microenvironment[J].Oncotarget, 2018, 9(5):6644-6651. doi:10.18632/oncotarget.24019 |
| 22 | ATTIEH Y, CLARK A G, GRASS C, et al. Cancer-associated fibroblasts lead tumor invasion through integrin-β3-dependent fibronectin assembly[J].J Cell Biol, 2017, 216(11):3509-3520. doi:10.1083/jcb.201702033 |
| 23 | LIN Y, LI Y, CHEN X, et al. YY1 mediated DCUN1D5 transcriptional activation promotes triple-negative breast cancer progression by targeting FN1/PI3K/AKT pathway[J]. Biol Direct, 2024, 19(1):42. doi:10.1186/s13062-024-00481-2 |
| 24 | YU S, YU X, SUN L, et al. GBP2 enhances glioblastoma invasion through Stat3/fibronectin pathway[J]. Oncogene, 2020, 39(27):5042-5055. doi:10.1038/s41388-020-1348-7 |
| 25 | BAO H, HUO Q, YUAN Q, et al. Fibronectin 1: A Potential Biomarker for Ovarian Cancer[J].Dis Markers, 2021, 2021(6):1-11. doi:10.1155/2021/5561651 |
| 26 | ZHANG X, LUO Y, CEN Y, et al. MACC1 promotes pancreatic cancer metastasis by interacting with the EMT regulator SNAI1[J]. Cell Death Dis, 2022, 13(11):923. doi:10.1038/s41419-022-05285-8 |
| 27 | GAMBHIR S, VYAS D, HOLLIS M, et al. Nuclear factor kappa B role in inflammation associated gastrointestinal malignancies[J]. World J Gastroenterol, 2015, 21(11):3174-83. doi:10.3748/wjg.v21.i11.3174 |
| 28 | CHEN X B, LI H Z, WEI X Y, et al. SERPINA1 promotes the invasion, metastasis, and proliferation of pancreatic ductal adenocarcinoma via the PI3K/Akt/NF-κB pathway[J]. Biochem Pharmacol, 2024, 230(2):116580. doi:10.1016/j.bcp.2024.116580 |
| 29 | ZUO X, ZHAO X, ZHANG X, et al. PTPN20 promotes metastasis through activating NF-κB signaling in triple-negative breast cancer[J].Breast Cancer Res, 2024, 26(1):1-16. doi:10.1186/s13058-024-01910-w |
| 30 | SUN W, QIN Y, WANG Z,et al. The NEAT1_2/miR-491 Axis Modulates Papillary Thyroid Cancer Invasion and Metastasis Through TGM2/NFκb/FN1 Signaling[J]. Front Oncol, 2021, 11:610547. doi:10.3389/fonc.2021.610547 |
/
| 〈 |
|
〉 |